Alnylam Pharmaceuticals

1,416 people · 0 jobs
‌

Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.

Industries

Employees

1,001-5,000

Links


Org chart

Collapse
Pushkal Garg
Chief Research & Development Officer
Vasant Jadhav
Chief Technology Officer
Kevin Fitzgerald
Chief Scientific Officer
Timothy Maines
Chief Technical Operations & Quality Officer
Christine Lindenboom
Chief Corporate Communications Officer
Kasha Witkos
SVP, International Region Head
Julie Milner
VP Head Of International Regulatory Affairs
Robert Hesslein
Chief Legal Officer & Corporate Secretary
Mike Tirozzi
Svp, Chief Information And Data Officer
Melissa Mclaughlin
Chief Human Resources Officer
Daniel Lee
VP Enterprise Strategy And Portfolio Analytics
Stephen Listzwan
Vice President, Global Strategic Sourcing
Sally Collins
Vice President, Head Of International, Rare Disease

Board & advisors